NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
13/09/2022
Voltar para busca
Dado oficial do USPTO
PHAIM AIM ANTIGENIC IMMUNE MODULATION
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PHAIM AIM ANTIGENIC IMMUNE MODULATION
ST13
US500000090770788Classe
5, 10, 35, 44
Pedido
90770788
Registro
6842815
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
13/09/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 35, 44
Data de depósito
12/06/2021
Data de registro
13/09/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/09/2022
Última transação
13/09/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
London, GB
Examinador
GOODMAN, WENDY
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Phaim Pharma Ltd
Representantes
Joseph L. Morales THE MORALES LAW FIRM
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Vaccines; Chemical preparations for the diagnosis of diabetes; Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations; Chemical preparations for medical purposes
Classe 10
Medical test kits for diabetes monitoring for home use; Testing instruments for medical diagnostic purposes; Blood glucose testing apparatus; Apparatus for carrying-out diagnostic tests for medical purposes; Diagnosticexaminationmonitoring equipment; Medical apparatus for testing the level of glucose in the blood; Medical apparatus and instruments; Medical diagnostic instruments; Medical testing instruments
Classe 35
Advertising services relating to pharmaceuticals for the treatment of diabetes; Advertising services relating to pharmaceuticals; Advertisingmarketing and promotional services; Advertising; Compilation of statistical data for use in scientific research; Compilation of statistical data relating to medical research; Advertising services to promote public awareness of medical conditions; Advertising services related to immune disorders; Advertising services related to autoimmune diseases
Classe 44
Diabetes screening services; Medical services in the field of diabetes; Providing information via the Internet in the field of diabetes; Medical screening; Health screening services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services for the diagnosis of conditions of the human body; Medical services; Medical diagnostic services; Medical services for the treatment of conditions of the human body; Medical testing services relating to the diagnosis and treatment of disease; Performing diagnosis of diseases; Medical information services provided via the Internet; Providing medical information; Medical analysis services for autoimmune disease diagnosis and prognosis
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
13/09/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/06/2022
PUBO
PUBLISHED FOR OPPOSITION
28/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/05/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
15/05/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
15/05/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
15/05/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
15/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2022
ALIE
ASSIGNED TO LIE
09/03/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/03/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/03/2022
GNSL
LETTER OF SUSPENSION E-MAILED
03/03/2022
CNSL
SUSPENSION LETTER WRITTEN
03/03/2022
DOCK
ASSIGNED TO EXAMINER
03/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/09/2021
NWAP
NEW APPLICATION ENTERED
16/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PHAIM AIM ANTIGENIC IMMUNE MODULATION ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.